Skip to main content
Erschienen in: International Journal of Colorectal Disease 11/2010

01.11.2010 | Original Article

Impact of obesity on surgical and oncological outcomes in the management of colorectal cancer

verfasst von: Laura A. Healy, Aoife M. Ryan, Ellis Sutton, Katherine Younger, Brain Mehigan, Richard Stephens, John V. Reynolds

Erschienen in: International Journal of Colorectal Disease | Ausgabe 11/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Obesity is an established risk factor for colorectal cancer, particularly in males, and may negatively impact on oncologic outcomes. The aim of this study was to examine the impact of body mass index (BMI) on mortality and morbidity, tumour pathology, and overall survival in a consecutive cohort of Irish colorectal cancer patients treated with curative intent.

Methods

A retrospective analysis of BMI data entered prospectively into a comprehensive electronic database of colorectal cancer patients was undertaken. Patients were excluded if they had emergency surgery, previous malignancy or the BMI was not recorded. Analysis was performed comparing genders, obese with non-obese and comparing BMI categories.

Results

Of the 414 patients, 10% were underweight (<20 kg/m2); 35% were normal weight (20–25 kg/m2); 37% were overweight (25–30 kg/m2), and 18% were obese (≥30.00 kg/m2). Obesity overall was not significantly associated with pathological stage (p = 0.099) or positive lymph node status (p = 0.109) or degree of nodal involvement (p = 0.068). Obesity was significantly (p<0.05) associated with more advanced pathological stage, node positivity and degree of nodal involvement in male only and colon cancer only analysis. There was no difference in the overall incidence of major (p = 0.244) and minor complications (p = 0.078) when comparing obese with non-obese, but pelvic abscesses were more common in obese patients (p = 0.037). The underweight cohort had a higher rate of major complications (p = 0.041), sepsis (p = 0.024) and post-operative death (p = 0.006). Survival was equivalent between BMI categories and obese and non-obese groups (p = 0.469).

Conclusion

Obesity was associated with more advanced tumours in males and in colon cancer patients only and with a higher risk of post-operative pelvic abscesses but no significant differences with non-obese cohorts in the main outcome measures of in-hospital mortality, major morbidity and survival. Conversely, the adverse consequences of under-nutrition were highlighted in this study.
Literatur
1.
Zurück zum Zitat Dignam JJ, Polite BN, Yothers G, Raich P, Colangelo L, O'Connell MJ et al (2006) Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 98:1647–1654CrossRefPubMed Dignam JJ, Polite BN, Yothers G, Raich P, Colangelo L, O'Connell MJ et al (2006) Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 98:1647–1654CrossRefPubMed
3.
Zurück zum Zitat Benoist S, Panis Y, Alves A, Valleur P (2000) Impact of obesity on surgical outcomes after colorectal resection. Am J Surg 179:275–281CrossRefPubMed Benoist S, Panis Y, Alves A, Valleur P (2000) Impact of obesity on surgical outcomes after colorectal resection. Am J Surg 179:275–281CrossRefPubMed
4.
Zurück zum Zitat Rullier E, Laurent C, Garrelon JL, Michel P, Saric J, Parneix M (1998) Risk factors for anastomotic leakage after resection of rectal cancer. Br J Surg 85:355–358CrossRefPubMed Rullier E, Laurent C, Garrelon JL, Michel P, Saric J, Parneix M (1998) Risk factors for anastomotic leakage after resection of rectal cancer. Br J Surg 85:355–358CrossRefPubMed
5.
Zurück zum Zitat Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Benson AB 3rd, Macdonald JS et al (2003) Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 98:484–495CrossRefPubMed Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Benson AB 3rd, Macdonald JS et al (2003) Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 98:484–495CrossRefPubMed
6.
Zurück zum Zitat Murphy TK, Calle EE, Rodriguez C, Kahn HS, Thun MJ (2000) Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol 152:847–854CrossRefPubMed Murphy TK, Calle EE, Rodriguez C, Kahn HS, Thun MJ (2000) Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol 152:847–854CrossRefPubMed
7.
Zurück zum Zitat Tsukada K, Miyazaki T, Kato H, Masuda N, Fukuchi M, Fukai Y et al (2004) Body fat accumulation and postoperative complications after abdominal surgery. Am Surg 70:347–351PubMed Tsukada K, Miyazaki T, Kato H, Masuda N, Fukuchi M, Fukai Y et al (2004) Body fat accumulation and postoperative complications after abdominal surgery. Am Surg 70:347–351PubMed
8.
Zurück zum Zitat Tsujinaka S, Konishi F, Kawamura YJ, Saito M, Tajima N, Tanaka O, Lefor AT (2008) Visceral obesity predicts surgical outcomes after laparoscopic colectomy for sigmoid colon cancer. Dis Colon Rectum 51(12):1757–1767CrossRefPubMed Tsujinaka S, Konishi F, Kawamura YJ, Saito M, Tajima N, Tanaka O, Lefor AT (2008) Visceral obesity predicts surgical outcomes after laparoscopic colectomy for sigmoid colon cancer. Dis Colon Rectum 51(12):1757–1767CrossRefPubMed
9.
Zurück zum Zitat Trevisan M, Liu J, Muti P et al (2001) Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomark Prev 10:937–941 Trevisan M, Liu J, Muti P et al (2001) Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomark Prev 10:937–941
10.
Zurück zum Zitat Cholangelo LA, Gapstur SM, Gann PH et al (2002) Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomark Prev 11:385–391 Cholangelo LA, Gapstur SM, Gann PH et al (2002) Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomark Prev 11:385–391
11.
Zurück zum Zitat Karnofsky DA, Burchenal JH (1949). The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed), Evaluation of chemotherapeutic agents. Columbia Univ Press pp. 196 Karnofsky DA, Burchenal JH (1949). The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed), Evaluation of chemotherapeutic agents. Columbia Univ Press pp. 196
12.
Zurück zum Zitat Oken MM, Creech RH, Tromey DC, Horton J, Davis TE, McFadden ET et al (1982) Toxicity and response criteria of the Eastern Cooperative Group. Am J Clin Oncol 5:649–655CrossRefPubMed Oken MM, Creech RH, Tromey DC, Horton J, Davis TE, McFadden ET et al (1982) Toxicity and response criteria of the Eastern Cooperative Group. Am J Clin Oncol 5:649–655CrossRefPubMed
13.
Zurück zum Zitat American Society of Anesthesiologists (1963) New classification of physical status. Anesthesiology 24:111 American Society of Anesthesiologists (1963) New classification of physical status. Anesthesiology 24:111
14.
Zurück zum Zitat Strul H, Kariv R, Leshno M, Halak A, Jakubowicz M, Santo M, Umansky M, Shirin H, Degani Y, Revivo M, Halpern Z, Arber N (2006) The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40–80 years. Am J Gastroenterol 101(2):255–262CrossRefPubMed Strul H, Kariv R, Leshno M, Halak A, Jakubowicz M, Santo M, Umansky M, Shirin H, Degani Y, Revivo M, Halpern Z, Arber N (2006) The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40–80 years. Am J Gastroenterol 101(2):255–262CrossRefPubMed
15.
Zurück zum Zitat World Health Organization Consultation on Obesity (1998) Preventing and managing the global epidemic: report of a WHO consultation on Obesity, Geneva, 3–5 June 1997, 1–276. World Health Organization, Geneva World Health Organization Consultation on Obesity (1998) Preventing and managing the global epidemic: report of a WHO consultation on Obesity, Geneva, 3–5 June 1997, 1–276. World Health Organization, Geneva
16.
Zurück zum Zitat Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG (2002) AJCC cancer staging manual, 6th ed, 6th edn. Springer, New York Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG (2002) AJCC cancer staging manual, 6th ed, 6th edn. Springer, New York
17.
Zurück zum Zitat Turnbull RB, Kyle K, Watson FR, Spratt J (1967) Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg 166:420–427CrossRefPubMed Turnbull RB, Kyle K, Watson FR, Spratt J (1967) Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg 166:420–427CrossRefPubMed
18.
Zurück zum Zitat Staib L, Link KH, Blatz A, Beger HG (2002) Surgery of colorectal cancer: surgical morbidity and five- and ten-year results in 2400 patients monoinstitutional experience. World J Surg 26:59–66CrossRefPubMed Staib L, Link KH, Blatz A, Beger HG (2002) Surgery of colorectal cancer: surgical morbidity and five- and ten-year results in 2400 patients monoinstitutional experience. World J Surg 26:59–66CrossRefPubMed
19.
Zurück zum Zitat Bokey EL, Chapuis PH, Fung C, Hughes WJ, Koorey SG, Brewer D, Newland RC (1995) Postoperative morbidity and mortality following resection of the colon and rectum for cancer. Dis Colon Rectum 38(5):480–487CrossRefPubMed Bokey EL, Chapuis PH, Fung C, Hughes WJ, Koorey SG, Brewer D, Newland RC (1995) Postoperative morbidity and mortality following resection of the colon and rectum for cancer. Dis Colon Rectum 38(5):480–487CrossRefPubMed
20.
Zurück zum Zitat Merkow RP, Bilimoria KY, McCarter MD, Bentrem DJ (2009) Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg 208(1):53–61CrossRefPubMed Merkow RP, Bilimoria KY, McCarter MD, Bentrem DJ (2009) Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg 208(1):53–61CrossRefPubMed
21.
Zurück zum Zitat Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M (2009) The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 125(1):171–180CrossRefPubMed Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M (2009) The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 125(1):171–180CrossRefPubMed
22.
Zurück zum Zitat Frezza EE, Wachtel MS, Chiriva-Internati M (2006) Influence of obesity on the risk of developing colon cancer. Gut 55:285–291CrossRefPubMed Frezza EE, Wachtel MS, Chiriva-Internati M (2006) Influence of obesity on the risk of developing colon cancer. Gut 55:285–291CrossRefPubMed
23.
Zurück zum Zitat Kim SE, Shim KN, Jung SA, Yoo K, Moon IH (2007) An association between obesity and the prevalence of colonic adenoma according to age and gender. J Gastroenterol 42:616–623CrossRefPubMed Kim SE, Shim KN, Jung SA, Yoo K, Moon IH (2007) An association between obesity and the prevalence of colonic adenoma according to age and gender. J Gastroenterol 42:616–623CrossRefPubMed
24.
Zurück zum Zitat Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, Tracy RP, Dobs A, Savage PJ (1999) Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 91:1147–1154CrossRefPubMed Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, Tracy RP, Dobs A, Savage PJ (1999) Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 91:1147–1154CrossRefPubMed
25.
Zurück zum Zitat Pischon T, Lahmann PH, Boeing H et al (2006) Body size and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98(13):920–931CrossRefPubMed Pischon T, Lahmann PH, Boeing H et al (2006) Body size and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98(13):920–931CrossRefPubMed
26.
Zurück zum Zitat Després JP, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444(14):881–887CrossRefPubMed Després JP, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444(14):881–887CrossRefPubMed
27.
Zurück zum Zitat Haydon AM, Macinnis RJ, English DR, Giles GG (2006) Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut 55(1):62–67CrossRefPubMed Haydon AM, Macinnis RJ, English DR, Giles GG (2006) Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut 55(1):62–67CrossRefPubMed
28.
Zurück zum Zitat Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA (2007) Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 99(6):433–441CrossRefPubMed Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA (2007) Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 99(6):433–441CrossRefPubMed
29.
Zurück zum Zitat Mullen JT, Moorman DW, Cavenport DL (2009) The obesity paradox body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg 250:166–172CrossRefPubMed Mullen JT, Moorman DW, Cavenport DL (2009) The obesity paradox body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg 250:166–172CrossRefPubMed
30.
Zurück zum Zitat Morgan K, McGee H, Watson D, Perry I, Barry M, Shelley E, Harrington J, Molcho M, Layte R, Tully N, van Lente E, Ward M, Lutomski J, Conroy R, Brugha R (2008) SLÁN 2007: survey of lifestyle, attitudes & nutrition in Ireland. Main report. Department of Health and Children, Dublin Morgan K, McGee H, Watson D, Perry I, Barry M, Shelley E, Harrington J, Molcho M, Layte R, Tully N, van Lente E, Ward M, Lutomski J, Conroy R, Brugha R (2008) SLÁN 2007: survey of lifestyle, attitudes & nutrition in Ireland. Main report. Department of Health and Children, Dublin
31.
Zurück zum Zitat Heys L, Fjeldstad I, Krogstad K, Kaasa S, Falkmer UG (2002) Nutritional status of patients with advanced cancer: the value of using the subjective global assessment of nutritional status as a screening tool. Palliat Med 16:33–42CrossRef Heys L, Fjeldstad I, Krogstad K, Kaasa S, Falkmer UG (2002) Nutritional status of patients with advanced cancer: the value of using the subjective global assessment of nutritional status as a screening tool. Palliat Med 16:33–42CrossRef
32.
Zurück zum Zitat Bauer J, Capra S, Ferguson M (2002) Use of the scored patient-generated subjective global assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 56:779–785CrossRefPubMed Bauer J, Capra S, Ferguson M (2002) Use of the scored patient-generated subjective global assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 56:779–785CrossRefPubMed
33.
Zurück zum Zitat Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69:491–497CrossRefPubMed Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69:491–497CrossRefPubMed
34.
Zurück zum Zitat Heys SD, Walker LG, Deehan DJ, Eremin OE (1998) Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg Edinb 43:163–168PubMed Heys SD, Walker LG, Deehan DJ, Eremin OE (1998) Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg Edinb 43:163–168PubMed
35.
Zurück zum Zitat Gupta D, Lammersfeld CA, Burrows JL, Dahlk SL, Vashi PG, Grutsch JF, Hoffman S, Lis CG (2004) Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer. Am J Clin Nutr 80:1634–1638PubMed Gupta D, Lammersfeld CA, Burrows JL, Dahlk SL, Vashi PG, Grutsch JF, Hoffman S, Lis CG (2004) Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer. Am J Clin Nutr 80:1634–1638PubMed
36.
Zurück zum Zitat Gupta D, Lammersfeld CA, Vashi PG, Burrows J, Lis CG, Grutsch JF (2005) Prognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer. Eur J Clin Nutr 59:35–40CrossRefPubMed Gupta D, Lammersfeld CA, Vashi PG, Burrows J, Lis CG, Grutsch JF (2005) Prognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer. Eur J Clin Nutr 59:35–40CrossRefPubMed
37.
Zurück zum Zitat Dixon MR, Haukoos JS, Udani SM, Naghi JJ, Arnell TD, Kumar RR (2003) Carcinoembryonic antigen and albumin predict survival in patients with advanced colon and rectal cancer. Arch Surg 138:962–966CrossRefPubMed Dixon MR, Haukoos JS, Udani SM, Naghi JJ, Arnell TD, Kumar RR (2003) Carcinoembryonic antigen and albumin predict survival in patients with advanced colon and rectal cancer. Arch Surg 138:962–966CrossRefPubMed
38.
Zurück zum Zitat Steinberg J, Erlichman C, Gadalla T, Fine S, Wong A (1992) Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid. Eur J Cancer 28A:1817–1820CrossRefPubMed Steinberg J, Erlichman C, Gadalla T, Fine S, Wong A (1992) Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid. Eur J Cancer 28A:1817–1820CrossRefPubMed
Metadaten
Titel
Impact of obesity on surgical and oncological outcomes in the management of colorectal cancer
verfasst von
Laura A. Healy
Aoife M. Ryan
Ellis Sutton
Katherine Younger
Brain Mehigan
Richard Stephens
John V. Reynolds
Publikationsdatum
01.11.2010
Verlag
Springer-Verlag
Erschienen in
International Journal of Colorectal Disease / Ausgabe 11/2010
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-010-0963-0

Weitere Artikel der Ausgabe 11/2010

International Journal of Colorectal Disease 11/2010 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.